[Layout: Two columns. A header is at the top of the page.]

144 IC&RC Alcohol and Drug Counselor (ADC) Certification Examination Study Guide

43 Teplinsky, E. (2023, Aug.). How alcohol increases your cancer risk and what to know about reducing it. Can-cernet. https://www.cancer.net/blog/2023-08/how-al-cohol-increases-your-cancer-risk-and-what-know-about-reducing-it

44 NIDA (2020). Common comorbidities with substance use dis-orders research report. National Institute on Drug Abuse. https://nida.nih.gov/publications/research-reports/com-mon-comorbidities-substance-use-disorders/introduc-tion

45 U.S. Department of Health and Human Services (2014). The health consequences of smoking—50 Years of Progress: A report of the Surgeon General. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Con-trol and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smok-ing and Health. http://www.ncbi.nlm.nih.gov/books/NBK179276/.

46 Health People 2030 (n.d.). Tobacco use. https://health.gov/healthypeople/objectives-and-data/browse-objec-tives/tobacco-use#cit1

47 Guydish, J., Passalacqua, E., Pagano, A., et al. (2016). An international systematic review of smoking preva-lence in addiction treatment. Addiction, 111(2), 220–230. doi: 10.1111/add.13099.

48 Apollonio, D., Philipps, R., & Bero, L. (2016). Interven-tions for tobacco use cessation in people in treatment for or recovery from substance use disorders. Cochrane Da-tabase System Review. doi: 10.1002/14651858.CD010274.pub2.

49 SAMHSA (2021). Key substance use and mental health in-dicators in the United States: Results from the 2020 Nation-al Survey on Drug Use and Health (HHS Publication No. PEP21-07-01-003, NSDUH Series H-56), p.A-48. Rock-ville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration.

50 National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health (2014). The health consequences of smoking—50 Years of Progress: A report of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention (US). http://www.ncbi.nlm.nih.gov/books/NBK179276/

51 CDC (2019). Cancer and tobacco use. Centers for Disease Control and Prevention. https://www.cdc.gov/vitalsigns/cancerandtobacco/index.html

52 Schwartz, A. G., & Cote, M. L. (2016). Epidemiology of lung cancer. Advances in Experimental Medicine and Biolo-gy, 893, 21–41. doi:10.1007/978-3-319-24223-1_2.

53 SAMHSA (2021). Treating substance use disorders among people with HIV. Advisory. Publication No. PEP20-06-04-007. https://store.samhsa.gov/sites/default/files/pep20-06-04-007.pdf

54 Centers for Disease Control and Prevention. (2020, Oct.). HIV basics: Basic statistics. https://www.cdc.gov/hiv/basics/statistics.html

55 HIV.gov (2023, Jan.). What are HIV and AIDS? https://www.hiv.gov/hiv-basics/overview/about-hiv-and-aids/what-are-hiv-and-aids

56 HIV.gov (2023, June). Substance use and HIV risk. https://www.hiv.gov/hiv-basics/hiv-prevention/reduc-ing-risk-from-alcohol-and-drug-use/substance-use-and-hiv-risk

57 Cernasev, A., Veve, M. P., Cory, T. J., Summers, N. A., et al. (2020). Opioid use disorders in people living with HIV/AIDS: A review of implications for patient outcomes, drug interactions, and neurocognitive disorders. Phar-macy (Basel), 11;8(3):168. doi: 10.3390/pharmacy8030168.

58 Hodder, S. L., Feinberg, J., Strathdee, S. A., Shoptaw, S., et al. (2021). The opioid crisis and HIV in the USA: Deadly synergies. The Lancet, 397(10279), 1139–1150. DOI:https://doi.org/10.1016/S0140-6736(21)00391-3

59 National Academies of Sciences, Engineering, and Med-icine (2020). Opportunities to improve opioid use disorder and infectious disease services: Integrating responses to a dual epidemic. Washington, DC: The National Academies Press. https://doi.org/10.17226/25626

60 National Institute on Drug Abuse. (2020, April). Part 3: The connection between substance use disorders and HIV. https://www.drugabuse.gov/publications/research-reports/common-comorbidities-sub-stance-use-disorders/part-3-connection-between-sub-stance-use-disorders-hiv

61 Centers for Disease Control and Prevention (2024). Viral hepatitis. https://www.cdc.gov/hepatitis/index.htm

62 NIDA (2024). Viral hepatitis. National Institute on Drug Abuse. https://nida.nih.gov/research-topics/viral-hepa-titis

63 Magiorkinis, G., et al. (2013). Integrating phylodynamics and epidemiology to estimate transmission diversity in viral epidemics. PLoS Computational Biology, 9(1): p.e1002876. https://doi.org/10.1371/journal.pcbi.1002876

64 CDC (2024, Jan.). Sexually transmitted infections surveil-lance, 2022. https://www.cdc.gov/std/statistics/2022/overview.htm

65 Haider, M. R., Kingori, C., Brown, M. J., et al. (2020). Illicit drug use and sexually transmitted infections among young adults in the US: Evidence from a nation-ally representative survey. International Journal of STD & AIDS, 31(13), 1238–1246. doi: 10.1177/0956462420950603